NCT03784586 (ACADEMY 1) is a clinical trial in Myotonic Dystrophy 1, sponsored by University of Campania Luigi Vanvitelli.

Who is sponsoring NCT03784586?

NCT03784586 is sponsored by University of Campania Luigi Vanvitelli.

What condition does NCT03784586 study?

NCT03784586 studies Myotonic Dystrophy 1, Sudden Cardiac Death.

Is NCT03784586 still recruiting?

NCT03784586 is currently status unknown. Last updated 18 June 2021.

Last reviewed 2021-06-18 · How we verify

NCT03784586: ACADEMY 1

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Sudden Cardiac Death Stratification in Myotonic Dystrophy Type 1 Patients

Status unknown Last updated 18 June 2021

What this trial tests

trial in Myotonic Dystrophy 1 in 70 participants. Status unknown.

Timeline

1 February 2012

Primary endpoint
30 June 2022

31 May 2023

Quick facts

Lead sponsor	University of Campania Luigi Vanvitelli
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	70
Start date	1 February 2012
Primary completion	30 June 2022
Estimated completion	31 May 2023
Sites	1 location across Italy

Conditions studied

Myotonic Dystrophy 1 — all drugs for Myotonic Dystrophy 1 →
Sudden Cardiac Death — all drugs for Sudden Cardiac Death →

Sponsor

University of Campania Luigi Vanvitelli

Who can join

Adults 18 to 75, any sex, with Myotonic Dystrophy 1 or Sudden Cardiac Death. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the study is to evaluate if the electrophysiological study (EPS) guided therapy, including the prophylactic implantation of implantable cardioverter defibrillator (ICD), in inducible patients, is able to improve survival in comparison with conventional therapy (CONV strategy) in Myotonic Dystrophy type 1 patients with conduction disorders.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Myotonic Dystrophy 1

Currently open trials in the same condition.

NCT07385443 — The Spanish National Registry for Myotonic Dystrophy Type 1 · recruiting
NCT06378216 — Myotonic Dystrophy Type 1 Congenital and Juvenile Form: From Diagnosis to Rehabilitation [MDCJ-NeuBeRe] · recruiting
NCT03981575 — Estab Biomarkers and Clinical Endpoints in Myotonic Dystrophy Type 1 (END-DM1) · recruiting

Other University of Campania Luigi Vanvitelli trials

Trials by the same sponsor.

NCT07590349 — Personalized Robotic Telerehabilitation for Upper Limb Functional Recovery After Stroke in a Home-Based Setting · NA · not yet recruiting
NCT06718452 — Tinnitus and Treatment With umPEA-LUT · NA · not yet recruiting
NCT07124676 — Prospective Study Comparing Two Classification Systems for Second-degree Vaginal Tears During Spontaneous Childbirth to · not yet recruiting
NCT07425912 — Real-World Evaluation of TouchCare Nano in Pediatric Type 1 Diabetes · active not recruiting
NCT06991816 — The Brain&Senses Study · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03784586 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Campania Luigi Vanvitelli
Last refreshed: 18 June 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03784586.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing